Flavoxate treatment of micturition disorders accompanying benign prostatic hypertrophy: a double-blind placebo-controlled multicenter investigation

Urologia Internationalis
T L DahmN Alexander

Abstract

To investigate the effect of flavoxate (Urispadol) treatment on patients with symptomatic benign prostatic hypertrophy (BPH), with the main weight on the irritative symptoms, a randomized, double-blind, parallel-group, placebo-controlled and multicenter investigation was carried out. Seventy patients entered the study, 37 were allocated to flavoxate treatment on a daily dose of 1,200 mg (400 mg t.i.d.) for 12 weeks, and 33 patients were allocated to placebo treatment. In spite of a sufficient power, the study did not discriminate the two treatment groups in a statistically significant way (p > 0.05), when considering the main endpoints: the irritative symptom score and the global patient evaluation. Conservative treatment of micturition disorders accompanying BPH with flavoxate in doses of 1,200 mg/day cannot be recommended for clinical use.

Citations

Aug 28, 2012·Current Urology Reports·Steven J WeissbartSteven Kaplan
Feb 25, 2011·Case Reports in Ophthalmology·Hasan RazmjooMohammadreza Akhlaghi
Oct 9, 2009·International Journal of Urology : Official Journal of the Japanese Urological Association·Yukio HommaUNKNOWN Japanese Society of Neurogenic Bladder
Jan 14, 2009·International Journal of Urology : Official Journal of the Japanese Urological Association·Osamu NishizawaYoshihiko Hirao
Feb 26, 2008·Pharmacotherapy·Patrick J Gallegos, Lawrence A Frazee
Nov 5, 2011·International Journal of Urology : Official Journal of the Japanese Urological Association·Yukio HommaUNKNOWN Japanese Urological Association
Mar 18, 2008·Urology·Nathan BittnerRobert W Galbreath
Dec 7, 2014·International Urogynecology Journal·Murat ZorRoger Roman Dmochowski
Jul 18, 2000·Baillière's Best Practice & Research. Clinical Obstetrics & Gynaecology·K E Andersson
Jun 9, 2006·The Aging Male : the Official Journal of the International Society for the Study of the Aging Male·A Wagg
Jul 11, 2012·Urologia Internationalis·A D AsimakopoulosE Finazzi-Agrò
Aug 30, 2008·British Journal of Clinical Pharmacology·Zakir Shaik MohammedKhan Rahat Ali
Dec 20, 2007·Current Opinion in Urology·James Armitage, Mark Emberton
Oct 19, 2007·The Cochrane Database of Systematic Reviews·C RoxburghN Dublin
Aug 16, 2003·British Journal of Clinical Pharmacology·C BroadhurstJ K Dhesi
Dec 17, 2009·The Aging Male : the Official Journal of the International Society for the Study of the Aging Male·Steven A KaplanSergio Forero-Schwanhaeuser
Nov 26, 1999·BJU International·K E AnderssonR Vela Navarrete
Jun 14, 2000·The Annals of Pharmacotherapy·J A Couture, L Valiquette

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.